Effects of HIV and combination antiretroviral therapy on cortico-striatal functional connectivity

AIDS

Volumn 29, Issue 6, 2015, Pages 703-712

  Ortega, Mario ^a   Brier, Matthew R ^a   Ances, Beau M ^a,b,c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WASHINGTON UNIVERSITY IN ST LOUIS   (United States)

Author keywords

Caudate; Combination antiretroviral therapy; HIV; HIV associated neurocognitive disorders; Putamen; Resting state functional connectivity; Striatum

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BRAIN ATROPHY; BRAIN CORTEX; BRAIN REGION; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CLINICAL ASSESSMENT; COGNITION; CONNECTOME; CONTROLLED STUDY; CORPUS STRIATUM; DEFAULT MODE NETWORK; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; PLASMA; PRIORITY JOURNAL; RESTING STATE NETWORK; SUBCORTEX; VENTRAL ATTENTION NETWORK; VIRUS LOAD; DRUG EFFECTS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV INFECTIONS; MIDDLE AGED; NERVE TRACT; NEUROIMAGING; PATHOPHYSIOLOGY; PROCEDURES;

ADULT; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CEREBRAL CORTEX; CORPUS STRIATUM; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; NEURAL PATHWAYS; NEUROIMAGING; NEUROPSYCHOLOGICAL TESTS;

EID: 84937888448     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000611     Document Type: Article

References (85)

1. Kaul M, Garden GA, Lipton SA. Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 2001; 410:988-994.
2. Anthony IC, Bell JE. The Neuropathology of HIV/AIDS. Int Rev Psychiatry 2008; 20:15-24.
3. Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, Leblanc S, et al. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol 2011; 17:3-16.
4. Jessen Krut J, Mellberg T, Price RW, Hagberg L, Fuchs D, Rosengren L, et al. Biomarker evidence of axonal injury in neuroasymptomatic HIV-1 patients. PLoS One 2014; 9:e88591.
5. Garvey LJ, Pavese N, Politis M, Ramlackhansingh A, Brooks DJ, Taylor-Robinson SD, et al. Increased microglia activation in neurologically asymptomatic HIV-infected patients receiving effective ART. AIDS 2014; 28:67-72.
6. Grant I, Franklin DR, Deutsch R, Woods SP, Vaida F, Ellis RJ, et al. Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline. Neurology 2014; 82:2055-2062.
7. Clifford DB, Ances BM. HIV-associated neurocognitive disorder. Lancet Infect Dis 2013; 13:976-986.
8. Holt JL, Kraft-Terry SD, Chang L. Neuroimaging studies of the aging HIV-1-infected brain. J Neurovirol 2012; 18:291-302.
9. Biswal B, Yetkin FZ, Haughton VM, Hyde JS. Functional connectivity in the motor cortex of resting human brain using echo-planar MRI. Magn Reson Med 1995; 34:537-541.
10. Fox MD, Snyder AZ, Vincent JL, Corbetta M, Van Essen DC, Raichle ME. The human brain is intrinsically organized into dynamic, anticorrelated functional networks. Proc Natl Acad Sci U S A 2005; 102:9673-9678.
11. Seeley WW, Crawford RK, Zhou J, Miller BL, Greicius MD. Neurodegenerative diseases target large-scale human brain networks. Neuron 2009; 62:42-52.
12. Smith SM, Fox PT, Miller KL, Glahn DC, Fox PM, Mackay CE, et al. Correspondence of the brain's functional architecture during activation and rest. Proc Natl Acad Sci U S A 2009; 106:13040-13045.
13. Damoiseaux JS, Rombouts SaRB, Barkhof F, Scheltens P, Stam CJ, Smith SM, et al. Consistent resting-state networks across healthy subjects. Proc Natl Acad Sci U S A 2006; 103:13848-13853.
14. Van den Heuvel MP, Mandl RCW, Kahn RS, Hulshoff Pol HE. Functionally linked resting-state networks reflect the underlying structural connectivity architecture of the human brain. Hum Brain Mapp 2009; 30:3127-3141.
15. Hampson M, Peterson BS, Skudlarski P, Gatenby JC, Gore JC. Detection of functional connectivity using temporal correlations in MR images. Hum Brain Mapp 2002; 15:247-262.
16. Thomas JB, Brier MR, Snyder AZ, Vaida FF, Ances BM. Pathways to neurodegeneration: effects of HIV and aging on resting-state functional connectivity. Neurology 2013; 80:1186-1193.
17. Wang X, Foryt P, Ochs R, Chung J-H, Wu Y, Parrish T, et al. Abnormalities in resting-state functional connectivity in early human immunodeficiency virus infection. Brain Connect 2011; 1:207-217.
18. Woods SP, Moore DJ, Weber E, Grant I. Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychol Rev 2009; 19:152-168.
19. Malaspina L, Woods SP, Moore DJ, Depp C, Letendre SL, Jeste D, et al. Successful cognitive aging in persons living with HIV infection. J Neurovirol 2011; 17:110-119.
20. Stout JC, Ellis RJ, Jernigan TL, Archibald SL, Abramson I, Wolfson T, et al. Progressive cerebral volume loss in human immunodeficiency virus infection: a longitudinal volumetric magnetic resonance imaging study. HIV Neurobehavioral Research Center Group. Arch Neurol 1998; 55:161-168.
21. BergerJR,ArendtG.HIVdementia:theroleofthebasalgangliaand dopaminergic systems. J Psychopharmacol 2000; 14:214-221.
22. Ances BM, Ortega M, Vaida F, Heaps J, Paul R. Independent effects of HIV, aging, and HAART on brain volumetric measures. J Acquir Immune Defic Syndr 2012; 59:469-477.
23. Becker JT, Sanders J, Madsen SK, Ragin A, Kingsley L, Maruca V, et al. Subcortical brain atrophy persists even in HAART-regulated HIV disease. Brain Imaging Behav 2011; 5:77-85.
24. Hardy DJ, Vance DE. The neuropsychology of HIV/AIDS in older adults. Neuropsychol Rev 2009; 19:263-272.
25. Tozzi V, Balestra P, Libertone R, Antinori A. Cognitive function in treated HIV patients. Neurobehav HIV Med 2010; 2:95-113.
26. Scott JC, Woods SP, Carey CL, Weber E, Bondi MW, Grant I. Neurocognitive consequences of HIV infection in older adults: an evaluation of the 'cortical' hypothesis. AIDS Behav 2011; 15:1187-1196.
27. Melrose RJ, Tinaz S, Castelo JMB, Courtney MG, Stern CE. Compromised fronto-striatal functioning in HIV: an fMRI investigation of semantic event sequencing. Behav Brain Res 2008; 188:337-347.
28. Ernst T, Yakupov R, Nakama H, Crocket G, Cole M, Watters M, et al. Declined neural efficiency in cognitively stable human immunodeficiency virus patients. Ann Neurol 2009; 65:316-325.
29. Barkhof F, Haller S, Rombouts SaRB. Resting-state functional MR imaging: a new window to the brain. Radiology 2014; 272:29-49.
30. Van Gorp WG, Miller EN, Satz P, Visscher B. Neuropsychological performance in HIV-1 immunocompromised patients: a preliminary report. J Clin Exp Neuropsychol 1989; 11:763-773.
31. Robertson KR, Smurzynski M, Parsons TD, Wu K, Bosch RJ, Wu J, et al. The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS 2007; 21:1915-1921.
32. Tozzi V, Balestra P, Bellagamba R, Corpolongo A, Salvatori MF, Visco-Comandini U, et al. Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors. J Acquir Immune Defic Syndr 2007; 45:174-182.
33. Yeo BTT, Krienen FM, Sepulcre J, Sabuncu MR, Lashkari D, Hollinshead M, et al. The organization of the human cerebral cortex estimated by intrinsic functional connectivity. J Neurophysiol 2011; 106:1125-1165.
34. Fischl B, Sereno MI, Dale AM. Cortical surface-based analysis. II: inflation, flattening, and a surface-based coordinate system. Neuroimage 1999; 9:195-207.
35. Fischl B. Automatically parcellating the human cerebral cortex. Cereb Cortex 2004; 14:11-22.
36. Dale AM, Fischl B, Sereno MI. Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage 1999; 9:179-194.
37. Desikan RS, Seagonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D, et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 2006; 31:968-980.
38. Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, et al. Whole brain segmentation: neurotechnique automated labeling of neuroanatomical structures in the human brain. Neuron 2002; 33:341-355.
39. Choi EY, Yeo BTT, Buckner RL. The organization of the human striatum estimated by intrinsic functional connectivity. J Neurophysiol 2012; 108:2242-2263.
40. Power JD, Barnes Ka, Snyder AZ, Schlaggar BL, Petersen SE. Spurious but systematic correlations in functional connectivity MRI networks arise from subject motion. Neuroimage 2012; 59:2142-2154.
41. Van Dijk KRa, Hedden T, Venkataraman A, Evans KC, Lazar SW, Buckner RL. Intrinsic functional connectivity as a tool for human connectomics: theory, properties, and optimization. J Neurophysiol 2010; 103:297-321.
42. Hallquist MN, Hwang K, Luna B. The nuisance of nuisance regression: spectral misspecification in a common approach to resting-state fMRI preprocessing reintroduces noise and obscures functional connectivity. Neuroimage 2013; 82:208-225.
43. Greve DN, Fischl B. Accurate and robust brain image alignment using boundary-based registration. Neuroimage 2009; 48:63-72.
44. Polimeni JR, Fischl B, Greve DN, Wald LL. Laminar analysis of 7T BOLD using an imposed spatial activation pattern in human V1. Neuroimage 2010; 52:1334-1346.
45. Arendt G, Hefter H, Elsing C, Strohmeyer GHJ. Motor dysfunction in HIV-infected patients without clinically detectable central-nervous deficit. Published Online First: 1990. http://www.springerlink.com/index/K76465858137QW16.pdf.
46. Picard N, Strick P. Imaging the premotor areas. Curr Opin Neurobiol 2001; 11:663-672.
47. Field AP. Meta-analysis of correlation coefficients: a Monte Carlo comparison of fixed- and random-effects methods. Psychol Methods 2001; 6:161-180.
48. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B 1995; 57:289-300.
49. Raichle ME, Macleod AM, Snyder AZ, Powers WJ, Gusnard DA, Shulman GL. A default mode of brain function. Proc Natl Acad Sci U S A 2001; 98:676-682.
50. Crews L, Patrick C, Achim CL, Everall IP, Masliah E. Molecular pathology of neuro-AIDS (CNS-HIV). Int J Mol Sci 2009; 10:1045-1063.
51. Lu S-M, Tremblay M-È, King IL, Qi J, Reynolds HM, Marker DF, et al. HIV-1 Tat-induced microgliosis and synaptic damage via interactions between peripheral and central myeloid cells. PLoS One 2011; 6:e23915.
52. Du Plessis S, Vink M, Joska Ja, Koutsilieri E, Stein DJ, Emsley R. HIV infection and the fronto-striatal system: a systematic review and meta-analysis of fMRI studies. AIDS 2014; 28:803-811.
53. Fama R, Rosenbloom MJ, Sassoon Sa, Rohlfing T, Pfefferbaum A, Sullivan EV. Thalamic volume deficit contributes to procedural and explicit memory impairment in HIV infection with primary alcoholism comorbidity. Brain Imaging Behav 2014; 8:611-620.
54. Van den Heuvel MP, Sporns O. Rich-club organization of the human connectome. J Neurosci 2011; 31:15775-15786.
55. Tomasi D, Volkow ND, Wang R, Telang F, Wang G, Chang L, et al. Dopamine transporters in striatum correlate with deactivation in the default mode network during visuospatial attention. PLoS One 2009; 4:e6102.
56. Jahfari S, Waldorp L, van den Wildenberg WPM, Scholte HS, Ridderinkhof KR, Forstmann BU. Effective connectivity reveals important roles for both the hyperdirect (fronto-subthalamic) and the indirect (fronto-striatal-pallidal) fronto-basal ganglia pathways during response inhibition. J Neurosci 2011; 31:6891-6899.
57. Zink CF, Pagnoni G, Martin ME, Dhamala M, Berns GS. Human striatal response to salient nonrewarding stimuli. J Neurosci 2003; 23:8092-8097.
58. Dang L, Donde A, Madison C, O'Neil JP, Jagust WJ. Striatal dopamine influences the default mode network to affect shifting between object features. J Cogn Neurosci 2012; 24:1960-1970.
59. Buckner RL, Andrews-Hanna JR, Schacter DL. The brain's default network: anatomy, function, and relevance to disease. Ann N Y Acad Sci 2008; 1124:1-38.
60. Thompson PM, Dutton RA, Hayashi KM, Toga AW, Lopez OL, Aizenstein HJ, et al. Thinning of the cerebral cortex visualized in HIV/AIDS reflects CD4R T lymphocyte decline. Proc Natl Acad Sci USA 2005; 102:15647-15652.
61. Thomas JB, Brier MR, Ortega M, Benzinger TL, Ances BM. Weighted brain networks in disease: centrality and entropy in human immunodeficiency virus and aging. Neurobiol Aging 2015; 36:401-412.
62. Becker KM, Heinrichs-Graham E, Fox HS, Robertson KR, Sandkovsky U, O'Neill J, et al. Decreased MEG beta oscillations in HIV-infected older adults during the resting state. J Neurovirol 2013; 19:586-594.
63. Wilson TW, Heinrichs-Graham E, Becker KM, Aloi J, Robertson KR, Sandkovsky U, et al. Multimodal neuroimaging evidence of alterations in cortical structure and function in HIV-infected older adults. Hum Brain Mapp 2014; 36:897-910.
64. DHHS Panel on Antiretroviral Guidelines for Adults. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Afr J Med Pract 2009; 5:79-104.
65. Caniglia EC, Cain LE, Justice A, Tate J, Logan R, Sabin C, et al. Antiretroviral penetration into the CNS and incidence of AIDSdefining neurologic conditions. Neurology 2014; 83:134-141.
66. Ellis R, Langford D, Masliah E. HIV and antiretroviral therapy in the brain: neuronal injury and repair. Nat Rev Neurosci 2007; 8:33-44.
67. Joska Ja, Gouse H, Paul RH, Stein DJ, Flisher AJ. Does highly active antiretroviral therapy improve neurocognitive function? A systematic review. J Neurovirol 2010; 16:101-114.
68. Juengst SB, Aizenstein HJ, Figurski J, Lopez OL, Becker JT. Alterations in the hemodynamic response function in cognitively impaired HIV/AIDS subjects. J Neurosci Methods 2007; 163:208-212.
69. Ge Y, Law M, Johnson G, Herbert J, Babb JS, Mannon LJ, et al. Dynamic susceptibility contrast perfusion MR imaging of multiple sclerosis lesions: characterizing hemodynamic impairment and inflammatory activity. Am J Neuroradiol 2005; 26:1539-1547.
70. Brydon L, Harrison NA, Walker C, Steptoe A, Critchley HD. Peripheral inflammation is associated with altered substantia nigra activity and psychomotor slowing in humans. Biol Psychiatry 2008; 63:1022-1029.
71. Young AC, Yiannoutsos CT, Hegde M, Lee E, Peterson J, Walter R, et al. Cerebral metabolite changes prior to and after antiretroviral therapy in primary HIV infection. Neurology 2014; 83:1592-1600.
72. Sailasuta N, Ross W, Ananworanich J, Chalermchai T, DeGruttola V, Lerdlum S, et al. Change in brain magnetic resonance spectroscopy after treatment during acute HIV infection. PLoS One 2012; 7:e49272.
73. Masliah E, Heaton RK, Marcotte TD, Ellis RJ, Wiley CA, Mallory M, et al. Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center. Ann Neurol 1997; 42:963-972.
74. Chang L, Andres M, Sadino J, Jiang CS, Nakama H, Miller E, et al. Impact of apolipoprotein E e4 and HIV on cognition and brain atrophy: antagonistic pleiotropy and premature brain aging. Neuroimage 2011; 58:1017-1027.
75. Ragin AB, Du H, Ochs R, Wu Y, Sammet CL, Shoukry A, et al. Structural brain alterations can be detected early in HIV infection. Neurology 2012; 79:2328-2334.
76. Gannon P, Khan MZ, Kolson DL. Current understanding of HIV-associated neurocognitive disorders pathogenesis. Curr Opin Neurol 2011; 24:275-283.
77. Barreiro P, Labarga P, Fernandez-Montero JV, Poveda E, de Mendoza C, Sainchez C, et al. Longitudinal changes in viral RNA concentration in patients with chronic hepatitis C and/or HIV infection in the absence of antiviral therapy. J Clin Virol 2013; 58:391-395.
78. Luz PM, Grinsztejn B, Velasque L, Pacheco AG, Veloso VG, Moore RD, et al. Long-term CD4R cell count in response to combination antiretroviral therapy. PLoS One 2014; 9:e93039.
79. Joska Ja, Westgarth-Taylor J, Myer L, Hoare J, Thomas KGF, Combrinck M, et al. Characterization of HIV-associated neurocognitive disorders among individuals starting antiretroviral therapy in South Africa. AIDS Behav 2011; 15:1197-1203.
80. Chang L, Wang G-J, Volkow ND, Ernst T, Telang F, Logan J, et al. Decreased brain dopamine transporters are related to cognitive deficits in HIV patients with or without cocaine abuse. Neuroimage 2008; 42:869-878.
81. Wang G-J, Chang L, Volkow ND, Telang F, Logan J, Ernst T, et al. Decreased brain dopaminergic transporters in HIV-associated dementia patients. Brain 2004; 127:2452-2458.
82. Obermann M, Kuper M, Kastrup O, Yaldizli O, Esser S, Thiermann J, et al. Substantia nigra hyperechogenicity and CSF dopamine depletion in HIV. J Neurol 2009; 256:948-953.
83. Cole DM, Beckmann CF, Oei NYL, Both S, van Gerven JMa, Rombouts SaRB. Differential and distributed effects of dopamine neuromodulations on resting-state network connectivity. Neuroimage 2013; 78:59-67.
84. Cools R. Dopaminergic control of the striatum for high-level cognition. Curr Opin Neurobiol 2011; 21:402-407.
85. Smith Y, Kieval JZ. Anatomy of the dopamine system in the basal ganglia. Trends Neurosci 2000; 23:S28-S33.